Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -18.511% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a CCN1C(=O)CSC1=Nc1ccc(C(=O)O)cc1
b COc1ccc(NC(=S)N2CCCN(Cc3cccc(Cl)c3)C2)cc1
c CCN1CCCC1CNC(=O)c1cc2c(=O)n(C)c3ccccc3c2n1C
d COc1ccccc1-c1nc(SCC(=O)NCc2ccco2)c2c(=O)n(C)c(=O)n(C)c2n1
e CCOCCCn1c(SCC(=O)Nc2cc(OC)ccc2OC)nc2ccccc2c1=O
Answer: c. CCN1CCCC1CNC(=O)c1cc2c(=O)n(C)c3ccccc3c2n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCCC1CNC(=O)c1cc2c(=O)n(C)c3ccccc3c2n1C
CCN1CCCC1CNC(=O)c1cc2c(=O)n(C)c3ccccc3c2n1C
N-[(1-ethylpyrrolidin-2-yl)methyl]-1,5-dimethyl-4-oxopyrrolo[3,2-c]quinoline-2-carboxamide